Those who take oral glucagon-like peptide-1 (GLP-1) medications, such as Wegovy tablets, are advised not to take the medication with morning coffee or tea. According to FDA prescribing information, Wegovy tablets should be taken on an empty stomach with up to 4 ounces of water — and no other liquids. Patients should wait at least 30 … Read more
By the time he turned ten, Jenna Ceriani’s son was too heavy to play football. The local league kicked the budding ballplayer out after he tipped the scales at 155 pounds — well above their 125-pound cap. The middle schooler’s weight had become a safety liability for smaller players on the team, they explained. “Every time … Read more
At 16 years old, Megan Rappa was missing school for what felt like a full system breakdown. She’d suffered irregular and painful periods for years before a gynecologist finally named her condition — but still, nothing changed. “Even with a diagnosis, my symptoms were just mine to deal with and there was not a solution … Read more
Stamie Giallourakis was on her deathbed in early 2021 when she made herself a promise. At the time, she was over 200 pounds and hospitalized with severe COVID-19. “I swore that if I survived — and I’m not being dramatic — I would try to once and for all be as healthy as I could … Read more
An unapproved weight loss drug is about to become available to more patients. Retatrutide — also known as “reta” — has been shown to produce dramatically greater weight loss than blockbuster drugs like Ozempic and Mounjaro. The experimental drug delivers a triple whammy by mimicking three hormones involved in appetite and metabolism: GLP-1, GIP and … Read more
Talk about losing face. By now, people are well aware of “Ozempic face,” the phenomenon in which people on GLP-1 medications notice saggy skin, sunken eyes and gaunt cheeks. Now, “temporal wasting” is the latest side effect that prematurely ages weight loss drug users, and has doctors concerned. Along with “Ozempic face,” another side effect … Read more
July 22 (Reuters) – The risk of hair loss in patients taking GLP-1 drugs for obesity or diabetes, while low, is higher than with other diabetes drugs, new studies suggest. At two or more years after starting treatment, the odds of a new diagnosis of alopecia in GLP-1 users were 37 percent higher than in … Read more
America is slimming down — one shot at a time. The number of US adults turning to blockbuster GLP-1 drugs like Ozempic and Wegovy for weight loss has hit a record high, nearly quadrupling in just two years. Now, the shift is showing up on the scale, with national obesity rates edging lower after years … Read more
Neurologists are warning that popular weight-loss medications could have severe negative effects on neurodegenerative conditions like ALS. Jinsy Andrews, MD, a neurologist and director of NYU Langone’s ALS Center, says the very mechanism that makes these drugs popular — rapid weight loss — can go against the biological needs of patients with neuromuscular disorders. GLP-1 agonists have shown … Read more
Ruth didn’t want to pay a plastic surgeon to give her the body of her dreams. She wanted to do it herself. Rather than forking over nearly $100,000 on traditional liposuction, under the supervision of a medical expert, the 55-year-old instead purchased a $95 kit of Korean fat-dissolving fluids online, pumped the potion into a … Read more
GLP-1 meds could be stifling your senses. The drugs, originally developed to manage diabetes, have exploded in use after being approved to treat obesity, with as many as 1 in 8 adults currently taking the jab. But those lean-seeking masses could end up losing more than just their apple bottoms, as new research suggests the meds can … Read more
A new weight-loss trend has people drinking a mixture of warm water and unflavored gelatin right before sitting down to a meal. Promoted by influencers across social media as a budget-friendly appetite suppressant, the practice’s effect has been compared to that of GLP-1 weight-loss medications. Experts, however, urge caution. There’s a simple biological explanation for … Read more
They’re sweeping the country — and raising questions in the locker room. At least one in eight American adults say they’ve used a GLP-1 drug such as Ozempic or Wegovy to lose weight or manage a chronic health condition, a stunning rise in just a few years. And while top athletes may seem unlikely candidates … Read more
Among those taking GLP-1 medications for weight loss, exercise rates are decreasing, according to new research. The study, set to be presented at ENDO 2026 (the Endocrine Society’s annual meeting) in Chicago this week, found that adults with obesity who lost weight with a GLP-1, such as Ozempic or Wegovy, “significantly reduced” their physical activity. In an Endocrine … Read more
Taking a shot at crime? GLP-1 medications like Ozempic and Mounjaro could be helping people make better choices — and not just with their food. A new study published today in the journal Criminology suggests these medications can actually make people less likely to act violently. Photographee.eu – stock.adobe.com Though GLP-1 agonists are prescribed to … Read more
Anti-fat jabs are throwing fashion a new curve. A staggering $5 billion in clothing inventory is at risk of going to waste thanks to fashionistas melting away their waists on GLP-1 drugs, per alarming new reports. As the A-list likes of singer Meghan Trainor and Sports Illustrated Swimsuit model Brooks Nader lead the charge in getting lean via Type 2 … Read more
Uncontrollable vomiting. Seizures. Throwing up blood. These are some of the horrifying symptoms people have reported after overdosing on GLP-1 drugs. Though the drugs have been around since 2005 to manage diabetes, they exploded in use after 2021, when Wegovy was approved by the FDA to treat obesity. Since then, GLP-1 use has quadrupled to … Read more
Millions of Medicare patients will be eligible for GLP-1 weight-loss drugs like Ozempic and Wegovy at a cut-rate $50 per month under an upcoming government program. Up to 14 million Medicare recipients are overweight and could qualify for the discounted drug program — known as the Medicare GLP-1 Bridge — which rolls out July 1 … Read more
GLP-1s seem to be fertile ground for a variety of health benefits. Recently, research has suggested the weight loss drugs might also help reduce risk of dementia and depression, help with ADHD symptoms and even reduce risks of breast cancer. Now, new findings suggest GLP-1s — popularly sold under brand names like Ozempic and Mounjaro … Read more
You may yet be able to lean out without losing out, as a new drug could save GLP-1 users from the flat fate of “Ozempic butt.” A symptom of rapid weight loss, Ozempic butt is characterized by a sudden loss of volume and muscle in key areas, leaving users looking and feeling deflated. And Americans … Read more